Sophia Genetics SA
NASDAQ:SOPH
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CH |
S
|
Sophia Genetics SA
NASDAQ:SOPH
|
321.4m USD |
Loading...
|
|
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
Loading...
|
|
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
29B USD |
Loading...
|
|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12.5B AUD |
Loading...
|
|
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY |
Loading...
|
|
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD |
Loading...
|
|
| SE |
|
Sectra AB
STO:SECT B
|
35.5B SEK |
Loading...
|
|
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
3.9B USD |
Loading...
|
|
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
25.2B CNY |
Loading...
|
|
| IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
281.4B INR |
Loading...
|
|
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR |
Loading...
|
Market Distribution
| Min | -57 027.8% |
| 30th Percentile | 1.3% |
| Median | 7.2% |
| 70th Percentile | 13.7% |
| Max | 3 663.7% |
Other Profitability Ratios
Sophia Genetics SA
Glance View
SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Sophia Genetics SA is -102.3%, which is above its 3-year median of -116.3%.
Over the last 3 years, Sophia Genetics SA’s Net Margin has increased from -210.2% to -102.3%. During this period, it reached a low of -210.2% on Sep 30, 2022 and a high of -95.9% on Dec 31, 2024.
